Expert panelists review recent updates in the treatment of advanced RCC following recent updates from the ESMO 2023 annual meeting and consider how they would approach specific scenarios in clinic.
EP. 7: Key Decision Factors in Selecting Frontline Therapy for Metastatic RCC
November 28th 2023Renowned oncologists discuss critical factors influencing their decisions for frontline therapy in metastatic renal cell carcinoma (RCC), including risk assessment, sites of metastasis, performance status, and treatment goals.
EP. 11: Novel Therapies for Advanced RCC: LITESPARK-005 and Treatment Sequencing
December 12th 2023Leading oncologists discuss advanced treatment options for patients with progressing renal cell carcinoma (RCC), focusing on the promising results from LITESPARK-005 and treatment sequencing strategies.
EP. 12: Triple Combination Therapies in RCC: Clinical Trial Insights
December 19th 2023Experts discuss the potential of triple combination therapies for high-risk renal cell carcinoma (RCC) patients and the challenges posed by their toxicity profiles, emphasizing the need for compelling clinical trial data.